Human Differentiated SH-SY5Y neuroblastoma cells treated with Granzyme K

ABSTRACT: Human Differentiated SH-SY5Y neuroblastoma cells treated with 150 nM GrK alone or together with 100 nM SCH79797 PAR-1 inhibitor to evaluate the impact of granzyme K (GrK) on neuronal functions.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Brain, Generation Of Neurons

DISEASE(S): Brain Cancer

SUBMITTER: daniela sorio  

LAB HEAD: Gabriela Constantin

PROVIDER: PXD064640 | Pride | 2025-06-24

REPOSITORIES: Pride